Skip to main content
. 2021 Feb 13;11(2):109. doi: 10.3390/metabo11020109

Table 3.

Metabolite levels significantly different between control and treated SF10417 tumors at early (D6 ± 2) and late (D14 ± 2) time points.

D6 ± 2
Metabolite Cramer-Rao Lower Bounds (%) Concentration (AU)
Control AG-881 BAY-1436032 Control AG-881 BAY-1436032
2-HG 4 5 5 7.73 ± 0.13 7.17 ± 0.11 5.98 ± 0.11
GSH 5 5 3 2.71 ± 0.05 1.73 ± 0.03 3.08 ± 0.04
NAA 4 3 3 6.37 ± 0.10 8.10 ± 0.06 8.57 ± 0.06
Lac 30 13 7 3.62 ± 0.19 - 3.13 ± 0.06
Glc 29 14 5 3.17 ± 0.20 3.98 ± 0.12 5.39 ± 0.12
mI 3 2 2 8.99 ± 0.07 7.00 ± 0.07 8.13 ± 0.04
Asp 6 5 5 11.37 ± 0.26 - 5.34 ± 0.12
Tau 5 4 3 5.27 ± 0.10 8.66 ± 0.08 13.07 ± 0.09
GABA 7 4 5 4.34 ± 0.11 6.75 ± 0.09 5.93 ± 0.09
Ala 36 11 10 0.47 ± 0.04 - 0.83 ± 0.03
Gln 16 6 4 1.71 ± 0.09 3.28 ± 0.07 2.67 ± 0.05
Glu 6 5 3 4.93 ± 0.10 5.92 ± 0.08 11.24 ± 0.09
Gly 5 3 5 12.68 ± 0.16 13.79 ± 0.11 10.25 ± 0.10
sI 30 13 10 0.29 ± 0.02 0.38 ± 0.03 0.18 ± 0.01
tCho 1 1 1 9.75 ± 0.04 7.99 ± 0.03 6.18 ± 0.03
tCr 3 2 2 9.77 ± 0.07 7.20 ± 0.05 8.03 ± 0.04
GLX 5 4 3 7.31 ± 0.15 11.48 ± 0.11 13.54 ± 0.11
D14 ± 2
2-HG 3 4 4 9.91 ± 0.16 6.56 ± 0.13 8.09 ± 0.12
GSH 5 5 5 1.71 ± 0.05 3.31 ± 0.06 2.62 ± 0.04
NAA 4 3 3 9.42 ± 0.17 6.01 ± 0.10 9.04 ± 0.08
Lac 7 15 7 2.43 ± 0.17 - -
Glc 10 8 12 3.19 ± 0.18 - -
mI 2 3 3 10.21 ± 0.09 9.72 ± 0.09 8.34 ± 0.07
Asp 6 7 7 15.89 ± 0.42 9.05 ± 0.32 5.50 ± 0.14
Tau 4 3 4 5.02 ± 0.12 7.46 ± 0.12 13.98 ± 0.13
GABA 8 5 5 4.71 ± 0.15 - 7.71 ± 0.12
Ala 16 42 17 0.96 ± 0.15 - -
Gln 25 9 5 0.88 ± 0.09 1.74 ± 0.10 3.20 ± 0.06
Glu 6 3 6 5.26 ± 0.14 6.93 ± 0.10 7.63 ± 0.12
Gly 4 4 5 7.88 ± 0.19 14.64 ± 0.14 10.58 ± 0.17
sI 20 19 16 0.22 ± 0.03 - 0.32 ± 0.01
tCho 1 1 1 9.28 ± 0.05 8.89 ± 0.05 6.06 ± 0.03
tCr 3 2 2 7.41 ± 0.11 10.62 ± 0.10 -
GLX 6 3 4 5.98 ± 0.18 7.90 ± 0.12 11.69 ± 0.15